| 000 | 01757 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516170829.0 | ||
| 264 | 0 | _c20150728 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1935-5548 | ||
| 024 | 7 |
_a10.2337/dc13-1030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKumareswaran, Kavita | |
| 245 | 0 | 0 |
_aFeasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study. _h[electronic resource] |
| 260 |
_bDiabetes care _c2014 |
||
| 300 |
_a1198-203 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aDietary Carbohydrates _xpharmacology |
| 650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin Infusion Systems |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aThabit, Hood | |
| 700 | 1 | _aLeelarathna, Lalantha | |
| 700 | 1 | _aCaldwell, Karen | |
| 700 | 1 | _aElleri, Daniela | |
| 700 | 1 | _aAllen, Janet M | |
| 700 | 1 | _aNodale, Marianna | |
| 700 | 1 | _aWilinska, Malgorzata E | |
| 700 | 1 | _aEvans, Mark L | |
| 700 | 1 | _aHovorka, Roman | |
| 773 | 0 |
_tDiabetes care _gvol. 37 _gno. 5 _gp. 1198-203 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/dc13-1030 _zAvailable from publisher's website |
| 999 |
_c23079121 _d23079121 |
||